These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6451722)

  • 1. [Studies on the absorption distribution and excretion of 14C-labelled sodium 7-[D(-)-alpha-(4-ethyl-2,3-dioxo-1-piperazine-carboxamido)-alpha-(4-hydroxyphenyl l) acetamido]-3-[(1-methyl-1H-tetrazol-5-yl) thiomethyl]-3-cephem-4-carboxylate (14C-cefoperazone) in rats and mice].
    Saikawa I; Takai A; Nakashima Y; Ikegami T; Hayakawa H; Takagi T; Yamauchi H
    Jpn J Antibiot; 1980 Oct; 33(10):1084-96. PubMed ID: 6451722
    [No Abstract]   [Full Text] [Related]  

  • 2. [The autoradiographic studies on the distribution of 14C-labelled sodium 7-[D(-)-alpha-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-alpha-(4-hydroxyphenyl)-acetamido]-3-[(1-methyl -1 H-tetrazol-5-yl) thiomethyl]-3-cephem-4-carboxylate (14C-cefoperazone) in rats and mice].
    Saikawa I; Takai A; Nakashima Y; Ikegami T; Hayakawa H; Takagi T; Yamauchi H
    Jpn J Antibiot; 1980 Oct; 33(10):1097-103. PubMed ID: 6451723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on absorption, distribution and excretion of 14C labelled sodium 7 beta-[(2R, 3S)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-3-hydroxybutanamido]-7-methoxy-3-[(1-methyl-1H-tetrazol-5-YL)thiomethyl]-3-cephem-4-carboxylate (14C-T-1982) in mice and rats].
    Saikawa I; Takai A; Nakashima Y; Ikegami T; Hayakawa H; Noguchi M; Yamauchi H; Shimizu H
    Jpn J Antibiot; 1982 Sep; 35(9):2163-73. PubMed ID: 7143717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The whole body autoradiographic studies on the distribution of 14C-labelled sodium 7 beta-[(2R, 3S)-2-(4-ethyl-2, 3-dioxo-1-piperazine-carboxamido)-3-hydroxybutanamido]-7 alpha-methoxy-3-[(1-methyl-1H-tetrazol-5-yl)thiomethyl]-3-cephem-4-carboxylate (14C-T-1982) in mice].
    Saikawa I; Takai A; Nakashima Y; Ikegami T; Hayakawa H; Noguchi M; Yamauchi H; Shimizu H
    Jpn J Antibiot; 1982 Sep; 35(9):2159-62. PubMed ID: 7143716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on beta-lactam antibiotics for medicinal purpose. XI. Studies on the metabolism of sodium 7-(D(-)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-alpha-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazole-5-yl)thiomethyl)-3-cephem-4-carboxylate (T-1551) (author's transl)].
    Saikawa I; Nakashima Y; Sakai H; Momonoi K; Ikegami T; Minami H; Hayakawa H; Ochiai H; Todo Y
    Yakugaku Zasshi; 1980 Jun; 100(6):625-40. PubMed ID: 6450829
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on beta-lactam antibiotics for medicinal purpose. X. Stability and degradation pattern of sodium 7-[D(--)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-alpha-(4-hydroxyphenyl)acetamido]-3-[(1-methyl-1H-tetrazol-5-yl)thiomethyl]-3-cephem-4-carboxylate (T-1551) in aqueous solution (author's transl)].
    Saikawa I; Momonoi K; Sakai H; Takashita Y; Ohashi T; Minami H; Yamamoto Y; Fukuoka Y
    Yakugaku Zasshi; 1979 Dec; 99(12):1207-18. PubMed ID: 544761
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on absorption, distribution and excretion of 14C labeled pivaloyloxymethyl (+)-(6R,7R)- 7-[(Z)-2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido]- 3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-oxo-5-thia- 1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (14C-T-2588) in rats and mice].
    Saikawa I; Maeda T; Nakashima Y; Sakai H; Hayakawa H; Onoda M; Matsutani H
    Jpn J Antibiot; 1986 Apr; 39(4):979-90. PubMed ID: 3761551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic.
    Tai M; Fukuoka Y; Yotsuji A; Kumano K; Takahata M; Mikami H; Yasuda T; Saikawa I; Mitsuhashi S
    Antimicrob Agents Chemother; 1982 Nov; 22(5):728-34. PubMed ID: 6983861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absorption, distribution and excretion of a new antithrombotic and vasodilating agent, cilostazol, in rat, rabbit, dog and man.
    Akiyama H; Kudo S; Shimizu T
    Arzneimittelforschung; 1985; 35(7A):1124-32. PubMed ID: 4074423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological study of beta-lactam antibiotics (15). Metabolism of sodium 7 beta-[(2R,3S)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-3- hydroxybutanamido]-7 alpha-methoxy-3- [1-methyl-1H-tetrazol-5-yl) thiomethyl]-3-cephem-4-carboxylate (T-1982)].
    Saikawa I; Nakashima Y; Tai M; Sakai H; Takakura I; Ikegami T; Hayakawa H; Shugimoto Y; Yamafuji T; Miyaura T
    Yakugaku Zasshi; 1983 Apr; 103(4):414-25. PubMed ID: 6415264
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on beta-lactam antibiotics for medicinal purpose. XIV. Stability and degradation pattern of sodium 7 beta-[(2R, 3S)-2-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-3-hydroxybutanamido]-7 alpha-methoxy-3-[(1-methyl-1H-tetrazol-5-yl)thiomethyl]-3-cephem-4- carboxylate (T-1982) in aqueous solution].
    Takano S; Tai M; Sakai H; Takakura I; Ochiai H; Sugimoto Y; Fukuoka Y; Saikawa I
    Yakugaku Zasshi; 1983 Jan; 103(1):62-72. PubMed ID: 6864450
    [No Abstract]   [Full Text] [Related]  

  • 12. Cefoperazone: absorption, excretion, distribution, and metabolism.
    Shimizu K
    Clin Ther; 1980; 3(Spec Issue):60-79. PubMed ID: 6446400
    [No Abstract]   [Full Text] [Related]  

  • 13. [Absorption, excretion and distribution of 14C-labelled 6-[D(-)-alpha-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-alpha-phenylacetamido] penicillanic acid (14C-T-1220) in rats and mice (author's transl)].
    Saikawa I; Takai A; Nakajima Y; Yasuda T; Shimizu E
    Jpn J Antibiot; 1977 Aug; 30(8):571-81. PubMed ID: 909145
    [No Abstract]   [Full Text] [Related]  

  • 14. [The autoradiographic studies on the distribution of 14C-labeled pivaloyloxymethyl (+)-(6R,7R)- 7-[(Z)-2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido]- 3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-o xo-5-thia- 1-azabicyclo [4.2.0]oct-2-ene-2-carboxylate (14C-T-2588) in mice].
    Saikawa I; Maeda T; Nakashima Y; Sakai H; Hayakawa H; Onoda M; Matsutani H
    Jpn J Antibiot; 1986 Apr; 39(4):991-5. PubMed ID: 3761552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on beta-lactam antibiotics for medicinal purposes. XXI. Studies on the metabolism of pivaloyloxymethyl (6R,7R)-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]- 3-[(5-methyl-2H-tetrazol-2-yl)methyl]-3-cephem-4-carboxylate (T-2588) (1)].
    Saikawa I; Tai M; Sugimoto Y; Imaizumi H; Takeda K; Sadaki H
    Yakugaku Zasshi; 1986 Jun; 106(6):466-77. PubMed ID: 3761157
    [No Abstract]   [Full Text] [Related]  

  • 16. Cefoperazone: pharmacokinetics in humans with normal and impaired renal function and pharmacokinetics in rats.
    Balant L; Dayer P; Rudhardt M; Allaz AF; Fabre J
    Clin Ther; 1980; 3(Spec Issue):50-9. PubMed ID: 6446399
    [No Abstract]   [Full Text] [Related]  

  • 17. [Absorption, distribution and excretion of 14C-cefatrizine (14C-S-640 P) in rat (author's transl)].
    Matsuzaki M; Matsumoto H; Ochiai K; Tashiro Y; Hino M
    Jpn J Antibiot; 1976 Apr; 29(4):391-402. PubMed ID: 933333
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the absorption, excretion and distribution of aclacinomycin A: absorption, excretion and distribution of 14C- or 3H-aclacinomycin A in mice, rats and rabbits (author's transl)].
    Iguchi H; Seryu Y; Kiyosaki T; Hori S; Tone H; Oki T
    Jpn J Antibiot; 1980 Feb; 33(2):169-78. PubMed ID: 6929359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal and fetal blood levels of moxifloxacin, levofloxacin, cefepime and cefoperazone.
    Ozyuncu O; Nemutlu E; Katlan D; Kir S; Beksac MS
    Int J Antimicrob Agents; 2010 Aug; 36(2):175-8. PubMed ID: 20418070
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.